bremelanotide
Showing 1 - 8 of 8
Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)
Recruiting
- Kidney Disease
- Bremelanotide
- RAAS inhibition therapy
-
Chula Vista, California
- +5 more
Jan 23, 2023
Hypoactive Sexual Desire Disorder Trial in Seoul (Bremelanotide, Placebo)
Recruiting
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 15, 2022
Nausea Trial in San Antonio (Bremelanotide, Zofran, Placebo)
Completed
- Nausea
- Bremelanotide
- +2 more
-
San Antonio, TexasICON Early Phase Serrvices, LLC
Mar 31, 2022
Hypoactive Sexual Desire Disorder Trial in London (Bremelanotide, Placebo)
Recruiting
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
London, United KingdomImperial College Healthcare NHS Trust
Mar 9, 2022
Hypoactive Sexual Desire Disorder Trial in Canada, United States (Bremelanotide, Placebo)
Completed
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Birmingham, Alabama
- +90 more
Mar 16, 2021
Hypoactive Sexual Desire Disorder Trial in Canada, United States (Bremelanotide, Placebo)
Completed
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Birmingham, Alabama
- +90 more
Jan 26, 2021
Female Sexual Arousal Disorder, Hypoactive Sexual Desire Disorder Trial in Canada, United States (bremelanotide)
Completed
- Female Sexual Arousal Disorder
- Hypoactive Sexual Desire Disorder
- bremelanotide
-
Birmingham, Alabama
- +67 more
Dec 2, 2014
Sexual Arousal Disorder Trial in United States (Bremelanotide)
Completed
- Sexual Arousal Disorder
- Bremelanotide
-
Huntsville, Alabama
- +19 more
Feb 22, 2011